MALAISE is the #11 most commonly reported adverse reaction for ESOMEPRAZOLE MAGNESIUM, manufactured by AstraZeneca Pharmaceuticals LP. There are 9,769 FDA adverse event reports linking ESOMEPRAZOLE MAGNESIUM to MALAISE. This represents approximately 2.0% of all 489,170 adverse event reports for this drug.
Patients taking ESOMEPRAZOLE MAGNESIUM who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE9,769 of 489,170 reports
MALAISE is a less commonly reported adverse event for ESOMEPRAZOLE MAGNESIUM, but still significant enough to appear in the safety profile.
Other Side Effects of ESOMEPRAZOLE MAGNESIUM
In addition to malaise, the following adverse reactions have been reported for ESOMEPRAZOLE MAGNESIUM:
MALAISE has been reported as an adverse event in 9,769 FDA reports for ESOMEPRAZOLE MAGNESIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with ESOMEPRAZOLE MAGNESIUM?
MALAISE accounts for approximately 2.0% of all adverse event reports for ESOMEPRAZOLE MAGNESIUM, making it a notable side effect.
What should I do if I experience MALAISE while taking ESOMEPRAZOLE MAGNESIUM?
If you experience malaise while taking ESOMEPRAZOLE MAGNESIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.